• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺叶状肿瘤:15 年多中心临床回顾。

Mammary phyllodes tumour: a 15-year multicentre clinical review.

机构信息

Department of Surgery, Division of Breast Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

J Clin Pathol. 2018 Jun;71(6):493-497. doi: 10.1136/jclinpath-2017-204827. Epub 2017 Nov 16.

DOI:10.1136/jclinpath-2017-204827
PMID:29146885
Abstract

AIMS

Phyllodes tumour (PT) is an uncommon fibroepithelial tumour of the breast. It has a spectrum of aggressiveness in biological behaviour with chance of local recurrence and, occasionally, metastasis.

METHODS

A 15-year retrospective review from a multicentre database in Hong Kong was performed.

RESULTS

Clinical and pathological records of 465 patients with 469 PTs between 1998 and 2014 were reviewed. Median age of occurrence was 44 years (range 12-86 years). 281 (59.9%) PTs were benign, 124 (26.4%) were borderline and 64 (13.6%) were malignant. About half of all PTs (239, 51.5%) were between 2 and 5 cm while another 186 (40.1%) were >5 cm in size. Most PT (84.6%) were radiologically benign. Breast-conserving surgery (BCS) was feasible in 384 (82%) patients, whereas 84 (18%) patients had mastectomy. Multivariate analysis found that positive surgical margin (P<0.001) and BCS (P<0.001) were the only significant risk factors for local recurrence, while large tumour size (P=0.008) and malignant PT histotype (P<0.001) were the only significant risk factors for metastasis. Long-term prognosis of benign and borderline PT was excellent. After median follow-up interval of 85 months (range 12-180 months), the disease-specific survival of benign, borderline and malignant PT were 99.6%, 100% and 90.6%, respectively.

CONCLUSIONS

Local recurrence of PTs occurs irrespective of the tumour grade. Surgical margin is the only amendable factor to reduce the chance of recurrence.

摘要

目的

叶状肿瘤(PT)是一种罕见的乳腺纤维上皮性肿瘤。它在生物学行为上具有一定的侵袭性,有局部复发的可能,偶尔还会发生转移。

方法

对来自香港多中心数据库的 15 年回顾性研究进行了分析。

结果

对 1998 年至 2014 年间的 465 例 469 例 PT 患者的临床和病理记录进行了回顾。发病中位年龄为 44 岁(范围 12-86 岁)。281 例(59.9%)PT 为良性,124 例(26.4%)为交界性,64 例(13.6%)为恶性。所有 PT 中有一半(239 例,51.5%)大小在 2 至 5cm 之间,另外 186 例(40.1%)大小>5cm。大多数 PT(84.6%)影像学上表现为良性。384 例(82%)患者可行保乳手术(BCS),84 例(18%)患者行乳房切除术。多变量分析发现,阳性切缘(P<0.001)和 BCS(P<0.001)是局部复发的唯一显著危险因素,而肿瘤较大(P=0.008)和恶性 PT 组织学类型(P<0.001)是转移的唯一显著危险因素。良性和交界性 PT 的长期预后良好。在中位随访时间 85 个月(范围 12-180 个月)后,良性、交界性和恶性 PT 的疾病特异性生存率分别为 99.6%、100%和 90.6%。

结论

PT 局部复发与肿瘤分级无关。切缘是唯一可降低复发几率的可改变因素。

相似文献

1
Mammary phyllodes tumour: a 15-year multicentre clinical review.乳腺叶状肿瘤:15 年多中心临床回顾。
J Clin Pathol. 2018 Jun;71(6):493-497. doi: 10.1136/jclinpath-2017-204827. Epub 2017 Nov 16.
2
Recurrent phyllodes tumours of the breast: pathological features and clinical implications.复发性乳腺叶状肿瘤:病理特征及临床意义
ANZ J Surg. 2006 Jun;76(6):476-80. doi: 10.1111/j.1445-2197.2006.03754.x.
3
Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.良性及交界性叶状肿瘤局部复发风险:一项基于丹麦人群的回顾性研究
Ann Surg Oncol. 2016 May;23(5):1543-8. doi: 10.1245/s10434-015-5041-y. Epub 2015 Dec 29.
4
Management of phyllodes breast tumors.乳腺叶状肿瘤的处理。
Breast J. 2011 Mar-Apr;17(2):129-37. doi: 10.1111/j.1524-4741.2010.01045.x. Epub 2011 Jan 19.
5
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.预测乳腺叶状肿瘤的临床行为:基于组织学标准和手术切缘的列线图。
J Clin Pathol. 2012 Jan;65(1):69-76. doi: 10.1136/jclinpath-2011-200368. Epub 2011 Nov 2.
6
Phyllodes tumors of the breast: a case series of 106 patients.乳腺叶状肿瘤:106例病例系列
Am J Surg. 2006 Aug;192(2):141-7. doi: 10.1016/j.amjsurg.2006.04.007.
7
Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience.乳腺叶状肿瘤:某大学医院经验的回顾性分析
Malays J Pathol. 2016 Apr;38(1):19-24.
8
Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.乳腺叶状肿瘤的外科治疗:172例回顾性分析
J Surg Oncol. 2005 Sep 1;91(3):185-94. doi: 10.1002/jso.20334.
9
Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.乳腺叶状肿瘤:间质过度生长和组织学分类是手术切缘阳性患者局部复发的有用预后预测因素。
Jpn J Clin Oncol. 2007 Oct;37(10):730-6. doi: 10.1093/jjco/hym099. Epub 2007 Oct 11.
10
Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.乳腺良性、交界性及恶性叶状肿瘤的临床特征比较。
Asian Pac J Cancer Prev. 2014;15(24):10791-5. doi: 10.7314/apjcp.2014.15.24.10791.

引用本文的文献

1
Exploring the clinical and histopathological characteristics on breast phyllodes tumors predictors and prognosis in a real world.在现实世界中探索乳腺叶状肿瘤的临床和组织病理学特征、预测因素及预后。
Front Oncol. 2025 Apr 15;15:1550429. doi: 10.3389/fonc.2025.1550429. eCollection 2025.
2
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.乳腺恶性叶状肿瘤:修订世界卫生组织“全面”诊断标准的理由
Histopathology. 2025 Aug;87(2):169-182. doi: 10.1111/his.15455. Epub 2025 Apr 13.
3
Borderline Phyllodes Breast Tumors: A Comprehensive Review of Recurrence, Histopathological Characteristics, and Treatment Modalities.
交界性叶状乳腺肿瘤:复发、组织病理学特征及治疗方式的综合综述
Curr Oncol. 2025 Jan 26;32(2):66. doi: 10.3390/curroncol32020066.
4
Retrospective analysis of core-needle and vacuum-assisted breast biopsies of B3 fibroepithelial lesions and correlation with results in subsequent surgical specimens.回顾性分析 B3 型纤维上皮性病变的空心针和真空辅助活检与后续手术标本结果的相关性。
J Cancer Res Clin Oncol. 2024 Sep 28;150(9):436. doi: 10.1007/s00432-024-05934-9.
5
Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.乳腺叶状肿瘤患者的边缘宽度与局部复发。
Ann Surg Oncol. 2024 Nov;31(12):8048-8056. doi: 10.1245/s10434-024-15892-8. Epub 2024 Jul 31.
6
Effect of different chemotherapy schemes on early-stage breast cancer patients with Low HER-2 expression.不同化疗方案对HER-2低表达早期乳腺癌患者的影响。
Pak J Med Sci. 2023 Sep-Oct;39(5):1355-1360. doi: 10.12669/pjms.39.5.7446.
7
Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study.巨乳腺叶状肿瘤和肉瘤的临床观点和结局:一项真实世界的回顾性研究。
BMC Cancer. 2023 Aug 28;23(1):801. doi: 10.1186/s12885-023-11279-2.
8
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).第三版乳腺交界性病变国际专家共识(B3 病变)
Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17.
9
The application of clinical variable-based nomogram in predicting overall survival in malignant phyllodes tumors of the breast.基于临床变量的列线图在预测乳腺恶性叶状肿瘤总生存中的应用。
Front Genet. 2023 May 30;14:1133495. doi: 10.3389/fgene.2023.1133495. eCollection 2023.
10
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists.当前乳腺叶状肿瘤管理的临床实践:外科医生和肿瘤学家的国际横断面研究。
Breast Cancer Res Treat. 2023 Jun;199(2):293-304. doi: 10.1007/s10549-023-06896-1. Epub 2023 Mar 6.